Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Diabetologia|February 1, 1992
Effect of phospholipase treatment on insulin receptor signal transductionG Zoppini, C R KahnDiabetes, Nutrition & Metabolism|July 10, 2003
Self-reported exercise and quality of life in young type 1 diabetic subjectsG Zoppini, M Carlini, M MuggeoJournal of Endocrinological Investigation|February 11, 2012
The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects: a narrative reviewG Zoppini, G Targher, E BonoraDiabetes/Metabolism Research and Reviews|August 10, 1999
Attending the diabetes center is associated with reduced cardiovascular mortality in type 2 diabetic patients: the Verona Diabetes StudyG Zoppini, G Verlato, E Bonora, et al.Journal of Endocrinological Investigation|March 24, 2011
Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence?G Targher, M Chonchol, I Pichiri, et al.European Journal of Clinical Investigation|April 1, 1994
Phosphotyrosine protein profiles in monocytes after insulin and IGF-1 stimulationG Zoppini, P Galante, M Zardini, et al.Journal of Endocrinological Investigation|May 19, 1998
Insulin induces tyrosine dephosphorylation of a 92 kDA protein in suspended monocytesG Zoppini, P Galante, M Zardini, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 24, 2004
Insulin sensitivity and hepatic steatosis in obese subjects with normal glucose toleranceC Venturi, G Zoppini, C Zamboni, et al.Alimentary Pharmacology & Therapeutics|October 18, 2005
Review article: type 2 diabetes and chronic liver disease in the Verona diabetes studyM Trombetta, G Spiazzi, G Zoppini, et al.Diabetic Medicine : a Journal of the British Diabetic Association|September 3, 2011
Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liverG Targher, I Pichiri, G Zoppini, et al.Pageof 6